Back
Speaker illustration

Doctor Sina Fathieh

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Presentations

Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)

Event: ESC Congress 2025

Topic: Noninvasive Diagnostic Methods

Session: Pathophysiology of ischaemic heart disease

Access
Like
Thumbnail

Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Biomarkers and assessing outcomes in coronary artery disease

Access
Like
Thumbnail

Examining the predictive value of plasma lysozyme for future all-cause mortality

Event: ESC Congress 2025

Topic: Biomarkers

Session: Biomarkers and molecular predictors in cardiovascular disease: from risk assessment to clinical application

Access
Like
Thumbnail

Predicting ECGs masquerading AS STEMI with machine learning

Event: ESC Congress 2024

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Biomarkers and machine learning in acute coronary syndromes: pathways to precision diagnosis and stratification

Access
Like
Thumbnail

Reduction in acute coronary events without excess out of hospital cardiac arrest during the COVID-19 lockdown of 2020 in new South Wales, Australia

Event: ESC Congress 2023

Topic: Public Health

Session: Innovations in public health and health economics (4)

Access
Like
Thumbnail

Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Preclinical and clinical laboratory markers in chronic coronary syndromes

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources